SENSEONICS HOLDINGS INC (SENS) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:SENS • US81727U3032

7.64 USD
+0.21 (+2.83%)
Last: Feb 9, 2026, 11:22 AM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

SENS gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 186 industry peers in the Health Care Equipment & Supplies industry. SENS scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. SENS is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year SENS has reported negative net income.
  • In the past year SENS has reported a negative cash flow from operations.
  • SENS had negative earnings in 4 of the past 5 years.
  • SENS had a negative operating cash flow in each of the past 5 years.
SENS Yearly Net Income VS EBIT VS OCF VS FCFSENS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M -300M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -45.57%, SENS is doing worse than 64.52% of the companies in the same industry.
  • SENS has a Return On Equity of -81.58%. This is comparable to the rest of the industry: SENS outperforms 41.40% of its industry peers.
Industry RankSector Rank
ROA -45.57%
ROE -81.58%
ROIC N/A
ROA(3y)-13.99%
ROA(5y)-136.34%
ROE(3y)-16.55%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SENS Yearly ROA, ROE, ROICSENS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K -1K

1.3 Margins

  • SENS's Gross Margin of 41.11% is on the low side compared to the rest of the industry. SENS is outperformed by 65.59% of its industry peers.
  • SENS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 41.11%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SENS Yearly Profit, Operating, Gross MarginsSENS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5K -10K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • SENS does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for SENS has been increased compared to 1 year ago.
  • Compared to 5 years ago, SENS has more shares outstanding
  • SENS has a worse debt/assets ratio than last year.
SENS Yearly Shares OutstandingSENS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
SENS Yearly Total Debt VS Total AssetsSENS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

  • Based on the Altman-Z score of -7.32, we must say that SENS is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of SENS (-7.32) is worse than 72.58% of its industry peers.
  • A Debt/Equity ratio of 0.45 indicates that SENS is not too dependend on debt financing.
  • SENS has a Debt to Equity ratio of 0.45. This is comparable to the rest of the industry: SENS outperforms 45.70% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF N/A
Altman-Z -7.32
ROIC/WACCN/A
WACC10.06%
SENS Yearly LT Debt VS Equity VS FCFSENS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M -150M

2.3 Liquidity

  • SENS has a Current Ratio of 6.23. This indicates that SENS is financially healthy and has no problem in meeting its short term obligations.
  • SENS has a Current ratio of 6.23. This is amongst the best in the industry. SENS outperforms 82.80% of its industry peers.
  • A Quick Ratio of 5.93 indicates that SENS has no problem at all paying its short term obligations.
  • With an excellent Quick ratio value of 5.93, SENS belongs to the best of the industry, outperforming 86.56% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 6.23
Quick Ratio 5.93
SENS Yearly Current Assets VS Current LiabilitesSENS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 37.31% over the past year.
  • SENS shows a strong growth in Revenue. In the last year, the Revenue has grown by 31.94%.
  • SENS shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.08% yearly.
EPS 1Y (TTM)37.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%46.25%
Revenue 1Y (TTM)31.94%
Revenue growth 3Y18.01%
Revenue growth 5Y1.08%
Sales Q2Q%89.89%

3.2 Future

  • SENS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.91% yearly.
  • The Revenue is expected to grow by 53.85% on average over the next years. This is a very strong growth
EPS Next Y30.95%
EPS Next 2Y1.96%
EPS Next 3Y5.01%
EPS Next 5Y8.91%
Revenue Next Year59.44%
Revenue Next 2Y64.87%
Revenue Next 3Y58%
Revenue Next 5Y53.85%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
SENS Yearly Revenue VS EstimatesSENS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 100M 200M 300M 400M 500M
SENS Yearly EPS VS EstimatesSENS Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 -5 -10 -15

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for SENS. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SENS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SENS Price Earnings VS Forward Price EarningsSENS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SENS Per share dataSENS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 -2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y1.96%
EPS Next 3Y5.01%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • SENS does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

SENSEONICS HOLDINGS INC

NASDAQ:SENS (2/9/2026, 11:22:16 AM)

7.64

+0.21 (+2.83%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-05
Earnings (Next)03-02
Inst Owners15.44%
Inst Owner Change-30.11%
Ins Owners2.77%
Ins Owner Change0.13%
Market Cap312.17M
Revenue(TTM)29.30M
Net Income(TTM)-63.77M
Analysts75.71
Price Target19.3 (152.62%)
Short Float %10.93%
Short Ratio9.33
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-24.33%
Min EPS beat(2)-50.62%
Max EPS beat(2)1.96%
EPS beat(4)3
Avg EPS beat(4)0.04%
Min EPS beat(4)-50.62%
Max EPS beat(4)34.09%
EPS beat(8)6
Avg EPS beat(8)2.76%
EPS beat(12)7
Avg EPS beat(12)11.3%
EPS beat(16)10
Avg EPS beat(16)45.79%
Revenue beat(2)1
Avg Revenue beat(2)4.03%
Min Revenue beat(2)-0.18%
Max Revenue beat(2)8.25%
Revenue beat(4)3
Avg Revenue beat(4)5.46%
Min Revenue beat(4)-0.18%
Max Revenue beat(4)10.29%
Revenue beat(8)6
Avg Revenue beat(8)4.18%
Revenue beat(12)9
Avg Revenue beat(12)4.49%
Revenue beat(16)11
Avg Revenue beat(16)3.01%
PT rev (1m)0%
PT rev (3m)-25.33%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-35.63%
EPS NY rev (1m)-8.15%
EPS NY rev (3m)-7.3%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-5.8%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.16%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 10.66
P/FCF N/A
P/OCF N/A
P/B 3.99
P/tB 4.04
EV/EBITDA N/A
EPS(TTM)-1.63
EYN/A
EPS(NY)-2.3
Fwd EYN/A
FCF(TTM)-1.37
FCFYN/A
OCF(TTM)-1.36
OCFYN/A
SpS0.72
BVpS1.91
TBVpS1.89
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -45.57%
ROE -81.58%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 41.11%
FCFM N/A
ROA(3y)-13.99%
ROA(5y)-136.34%
ROE(3y)-16.55%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.21
Health
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 39.87%
Cap/Sales 2.58%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.23
Quick Ratio 5.93
Altman-Z -7.32
F-Score5
WACC10.06%
ROIC/WACCN/A
Cap/Depr(3y)70.29%
Cap/Depr(5y)48.74%
Cap/Sales(3y)4.48%
Cap/Sales(5y)3.72%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)37.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%46.25%
EPS Next Y30.95%
EPS Next 2Y1.96%
EPS Next 3Y5.01%
EPS Next 5Y8.91%
Revenue 1Y (TTM)31.94%
Revenue growth 3Y18.01%
Revenue growth 5Y1.08%
Sales Q2Q%89.89%
Revenue Next Year59.44%
Revenue Next 2Y64.87%
Revenue Next 3Y58%
Revenue Next 5Y53.85%
EBIT growth 1Y20.49%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year28.8%
EBIT Next 3Y-10.15%
EBIT Next 5YN/A
FCF growth 1Y22.76%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y23.55%
OCF growth 3YN/A
OCF growth 5YN/A

SENSEONICS HOLDINGS INC / SENS FAQ

Can you provide the ChartMill fundamental rating for SENSEONICS HOLDINGS INC?

ChartMill assigns a fundamental rating of 2 / 10 to SENS.


Can you provide the valuation status for SENSEONICS HOLDINGS INC?

ChartMill assigns a valuation rating of 0 / 10 to SENSEONICS HOLDINGS INC (SENS). This can be considered as Overvalued.


What is the profitability of SENS stock?

SENSEONICS HOLDINGS INC (SENS) has a profitability rating of 0 / 10.


What is the financial health of SENSEONICS HOLDINGS INC (SENS) stock?

The financial health rating of SENSEONICS HOLDINGS INC (SENS) is 4 / 10.